# Hypertension, Pulmonary trials: 144 new since Nov 2024

Updated November 6, 2026.

144 clinical studies in Hypertension, Pulmonary were first posted on ClinicalTrials.gov from November 12, 2024 to November 6, 2026; 30 have an industry sponsor and 113 are recruiting or about to. The newest, NCT07923591, was posted on November 6, 2026: Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension... (United Therapeutics).

## The full list

New Hypertension, Pulmonary clinical trials: 144 rows for $7.20, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 9 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/hypertension-pulmonary

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 144
- Industry sponsored: 30
- Recruiting or not yet: 113
- Latest posted: November 6, 2026

## Newest trials

The newest 100 of 144, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 5, 2026 | NCT07918976 | Effects of Inhaled Nitric Oxide on Sublingual Microcirculation in Patients With Right Ventricular Dysfunction After Cardiac Surgery | Southeast University, China | Phase 2 | Completed | Cardiac Surgery Intensive Care Treatment, Pulmonary Hypertension, Right Ventricular (RV) Dysfunction | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918976) |
| November 4, 2026 | NCT07917416 | Home-based Inspiratory Muscle Training in Pulmonary Hypertension | Universidad Complutense de Madrid | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | 40 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917416) |
| November 4, 2026 | NCT07914933 | The Effect of Levosimendan on Pulmonary Artery Pressure and Right Ventricular Function in the Perioperative Period in Patients With CTEPH... | Meshalkin Research Institute of Pathology of Circulation | Not applicable | Recruiting | LEVOSIMENDAN, PULMONARY THROMBOENDARTERECTOMY, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary... | 50 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914933) |
| October 30, 2026 | NCT07907757 | Colchicine in Pulmonary Artery Hypertension Patients | Ain Shams University | Phase 2 | Not yet recruiting | Pulmonary Hypertension | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907757) |
| October 28, 2026 | NCT07899905 | A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022) | Merck Sharp & Dohme LLC | Phase 4 | Not yet recruiting | Hypertension, Pulmonary | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899905) |
| October 26, 2026 | NCT07895966 | Phase IIA Study of Belzutifan in EPAS1-, EGLN1-, or VHL-Mutant Erythrocytosis | University of Utah | Phase 2 | Not yet recruiting | Erythrocytosis, Pulmonary Hypertension, Thrombosis | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895966) |
| October 1, 2026 | NCT07851610 | Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0) | IRCCS SYNLAB SDN | Observational | Not yet recruiting | Right Ventricular Dysfunction, Cardiopulmonary Diseases, Pulmonary Hypertension | 2,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851610) |
| September 28, 2026 | NCT07844213 | Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone" | China National Center for Cardiovascular Diseases | Not applicable | Completed | Congenital Heart Disease, Pulmonary Hypertension | 30 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844213) |
| September 24, 2026 | NCT07839585 | A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure... | Merck Sharp & Dohme LLC | Phase 3 | Not yet recruiting | Pulmonary Hypertension | 352 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839585) |
| September 24, 2026 | NCT07837830 | Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH) | Valley Health System | Early phase 1 | Recruiting | Pulmonary Hypertension | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837830) |
| September 22, 2026 | NCT07834918 | Pulmonary Hypertension and RV Dysfunction in Myeloproliferative Neoplasms | Assiut University | Observational | Not yet recruiting | Myeloproliferative Neoplasm, Right Ventricular Dysfunction, Pulmonary Hypertension | 145 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834918) |
| September 16, 2026 | NCT07822997 | Quality of Life Questionnaire in Pulmonary Hypertension EMPHASIS-10: Brazilian Adaptation and Validation | Hospital de Clinicas de Porto Alegre | Observational | Recruiting | Pulmonary Hypertension, Quality of Life | 50 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822997) |
| September 16, 2026 | NCT07822750 | Predictors of Outcomes in Pulmonary Hypertension of the Newborn | Assiut University | Observational | Not yet recruiting | Hypertension, Pulmonary, Infant, Newborn, Diseases | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822750) |
| September 15, 2026 | NCT07821398 | Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis | Bastiaan Driehuys | Phase 2 | Not yet recruiting | Interstitial Lung Disease, Pulmonary Hypertension, Systemic Sclerosis | 51 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821398) |
| September 11, 2026 | NCT07816185 | A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) | Pulmovant, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases, Fibrosis | 376 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816185) |
| September 10, 2026 | NCT07814118 | Multimodal Physiologic State Intelligence Study | Truway Health, Inc. | Observational | Enrolling by invitation | Heart Failure, Cardiomyopathies, Pulmonary Hypertension, Myocarditis; Acute or Subacute, Myocarditis Due to Drug... | 25,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814118) |
| September 9, 2026 | NCT07810881 | Diagnostic Delay in PHTN | Assiut University | Observational | Not yet recruiting | Delayed Diagnosis Pulmonary Hypertension | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810881) |
| September 4, 2026 | NCT07804693 | Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary... | Silvia Ulrich Somaini | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude, Echocardiography, Pulmonary Resistance | 20 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804693) |
| September 4, 2026 | NCT07804524 | Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension... | Silvia Ulrich Somaini | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude, Echocardiography, Pulmonary... | 20 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804524) |
| September 4, 2026 | NCT07804472 | Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension... | Silvia Ulrich Somaini | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Six-minute Walk Test, High Altitude Effects, High... | 20 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804472) |
| September 3, 2026 | NCT07801963 | Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH | Silvia Ulrich Somaini | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Polygraphy, Sleep, Sleep Disordered Breathing (SDB)... | 20 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801963) |
| September 3, 2026 | NCT07801859 | Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in... | Silvia Ulrich Somaini | Not applicable | Not yet recruiting | High Altitude Effects, High Altitude, Pulmonary Vascular Disease, Pulmonary Arterial Hypertension (PAH), Heart Rate... | 20 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801859) |
| August 26, 2026 | NCT07787936 | GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry | Miedziowe Centrum Zdrowia SA | Observational | Not yet recruiting | Heart Failure With Preserved Ejection Fraction, Obesity, Diastolic Heart Failure, Pulmonary Hypertension, Iron... | 150 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787936) |
| August 20, 2026 | NCT07777445 | Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD) | Silvia Ulrich Somaini | Not applicable | Recruiting | Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) | 40 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777445) |
| August 20, 2026 | NCT07777367 | Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases | Silvia Ulrich Somaini | Not applicable | Recruiting | Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) | 40 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777367) |
| August 17, 2026 | NCT07768644 | Nailfold Capillaroscopy in PH | University of Glasgow | Observational | Recruiting | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Hypertension (World Health Organization Group 3)... | 60 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768644) |
| August 12, 2026 | NCT07760441 | Cardiorespiratory Assessment Prior to Scoliosis Surgery: a 10-year Experience at a Specialized Scoliosis Center | Poitiers University Hospital | Observational | Active not recruiting | Scoliosis, Restrictive Pulmonary Disease, Pulmonary Hypertension, Restrictive Breathing Pattern | 174 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760441) |
| August 10, 2026 | NCT07754981 | Self-Help Booklets for Sleep in Adults With Pulmonary Hypertension | University of Sheffield | Not applicable | Not yet recruiting | Pulmonary Hypertension, Insomnia, Sleep Hygiene | 60 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754981) |
| August 10, 2026 | NCT07754591 | Comparison of Dynamic Compliance and Airway Resistance in Pressure-Controlled Versus Volume-Controlled Ventilation in Children Undergoing... | Nilratan Sircar Medical College | Not applicable | Completed | Atrial Septal Defect, Ventricular Septal Defects, Pulmonary Hypertension, Intracardiac and Septal Defects | 72 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754591) |
| August 3, 2026 | NCT07742046 | Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease | Tobias Rutz | Not applicable | Enrolling by invitation | Pulmonary Hypertension, Right Ventricular Outflow Tract Dysfunction, Fontan Circulation | 130 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742046) |
| July 10, 2026 | NCT07694713 | Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation | Assiut University | Observational | Not yet recruiting | COPD Exacerbation (AECOPD), Pulmonary Hypertension | 115 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694713) |
| June 30, 2026 | NCT07676786 | Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients | Stefan Lujinschi | Observational | Not yet recruiting | Pulmonary Hypertension (PH), End Stage Kidney Disease (ESRD), Hemodialysis Patients, Volume Overload, Volume... | 30 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676786) |
| June 25, 2026 | NCT07667829 | Vasopressor Agents in Pulmonary Hypertension Crisis | China National Center for Cardiovascular Diseases | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary | 75 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667829) |
| June 25, 2026 | NCT07667673 | Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH | Istanbul University - Cerrahpasa | Observational | Active not recruiting | Pulmonary Hypertension, Pulmonary Arterial Hypertension, Right Ventricular Function | 50 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667673) |
| June 25, 2026 | NCT07667595 | Correlation Between CT Pulmonary Angiography Metrics and Right Heart Catheterization Parameters in Pre-Capillary Pulmonary Hypertension | Assiut University | Observational | Not yet recruiting | Pulmonary Hypertension, Precapillary Pulmonary Hypertension, Right Heart Catheterisation, CT Angiography | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667595) |
| June 23, 2026 | NCT07663799 | Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial Prospective | The University of Hong Kong | Observational | Not yet recruiting | Congenital Heart Disease, Pulmonary Hypertension, Heart Failure, Coronary Heart Disease (CHD), Apple Watch | 20 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663799) |
| June 23, 2026 | NCT07662655 | Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge... | Xiamen Cardiovascular Hospital, Xiamen University | Early phase 1 | Recruiting | Pulmonary Hypertension, Pulmonary Hypertension Associated With HFpEF | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662655) |
| June 17, 2026 | NCT07653958 | Risk Factor Assessment for Acute Pulmonary Hypertension Crisis | Peking Union Medical College Hospital | Observational | Recruiting | Pulmonary Hypertension, Pulmonary Hypertension Crisis | 5,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653958) |
| June 15, 2026 | NCT07647549 | Pulmonary Hypertension (PH) Biorepository for Translational Research | National Institutes of Health Clinical Center (CC) | Observational | Recruiting | Pulmonary Hypertension | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07647549) |
| June 11, 2026 | NCT07641400 | Pulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Emergency Department With Dyspnea | Antalya Health Sciences University | Observational | Not yet recruiting | Emergency Department Patients, Pulmonary Hypertension, Pulmonary Embolism | 80 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641400) |
| May 29, 2026 | NCT07614438 | Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery, | Fondation Hôpital Saint-Joseph | Phase 2 | Not yet recruiting | Anesthesia, Pulmonary Hypertension, Chronic Pulmonary Thromboembolism, Vasopressor | 90 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614438) |
| May 29, 2026 | NCT07613216 | A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of... | Cosmos Rx, Inc | Observational | Not yet recruiting | Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis Lung, Pulmonary Hypertension, Usual Interstitial Pneumonia | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613216) |
| May 18, 2026 | NCT07592637 | Lung Disease and FLNA Mutations | University Hospital, Lille | Not applicable | Not yet recruiting | Emphysema | 70 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592637) |
| May 8, 2026 | NCT07576894 | Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease | University of Colorado, Denver | Not applicable | Recruiting | COPD, Pulmonary Hypertension, Exercise, Right Ventricular (RV) Dysfunction, Exercise Training | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576894) |
| May 4, 2026 | NCT07563608 | Prevalence, Pathogenesis, and Prognosis of Pulmonary Hypertension in Dialysis Patients | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Pulmonary Hypertension | 70 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563608) |
| May 4, 2026 | NCT07563322 | Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension | Vanderbilt University Medical Center | Not applicable | Recruiting | Pulmonary Hypertension | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563322) |
| May 1, 2026 | NCT07561034 | The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease | University of Rochester | Not applicable | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561034) |
| April 29, 2026 | NCT07556185 | MedlyPeds Feasibility Study | The Hospital for Sick Children | Not applicable | Recruiting | Pediatric Heart Failure, Congenital Heart Disease (CHD), Acquired Heart Disease, Pulmonary Hypertension, Post Cardiac... | 30 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556185) |
| April 21, 2026 | NCT07542067 | Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With... | Fundación Neumologica Colombiana | Phase 1/2 | Completed | Systemic Sclerosis Pulmonary, Pulmonary Hypertension, Pulmonary Fibrosis | 1 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07542067) |
| April 17, 2026 | NCT07537517 | Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension. | Hospital General Universitario Gregorio Marañon | Observational | Recruiting | Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension (PH), Heart Failure | 150 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537517) |
| April 17, 2026 | NCT07535398 | Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure | Marmara University | Not applicable | Recruiting | Elevated Pulmonary Artery Pressure | 12 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07535398) |
| April 13, 2026 | NCT07522203 | Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon... | Istanbul Mehmet Akif Ersoy Educational and Training Hospital | Observational | Recruiting | CTEPH, Pulmonary Hypertension (PH) | 70 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07522203) |
| April 6, 2026 | NCT07512310 | Non-Invasive and Invasive Assessment of Heart Filling Pressure | University Hospital, Essen | Observational | Completed | Heart Failure, Pulmonary Hypertension, Ventricular Dysfunction, Left, Ventricular Dysfunction | 623 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512310) |
| March 27, 2026 | NCT07495774 | Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes | Guangdong Provincial People's Hospital | Observational | Recruiting | Pulmonary Hypertension | 450 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495774) |
| March 23, 2026 | NCT07487441 | Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept. | Franz Rischard, DO | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487441) |
| March 19, 2026 | NCT07481877 | Portosystemic Shunt-associated Pulmonary Hypertension Multi-center Prospective Cohort Study | Chinese Pulmonary Vascular Disease Research Group | Observational | Not yet recruiting | Portosystemic Shunt, Pulmonary Hypertension | 300 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481877) |
| March 17, 2026 | NCT07477197 | Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Adult Congenital Heart Disease, Pulmonary Hypertension, Connective Tissue Disease, Other Cardiovascular Conditions | 5,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477197) |
| March 16, 2026 | NCT07473700 | Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease | Tectonic Operating Company, Inc. | Phase 2 | Recruiting | Hypertension, Pulmonary, Lung Diseases, Interstitial | 25 | Poland, Romania, Serbia, South Korea, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07473700) |
| March 10, 2026 | NCT07462260 | Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) | Sindh Institute of Cardiovascular Diseases | Phase 2/3 | Completed | Pulmonary Hypertension, Rheumatic Valvular Heart Disease | 100 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462260) |
| March 5, 2026 | NCT07453017 | Electrical Impedance Tomography for Assessment of Pulmonary Hypertension | University of Sao Paulo General Hospital | Not applicable | Recruiting | Pulmonary Hypertension, Pulmonary Thromboembolisms | 120 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07453017) |
| March 3, 2026 | NCT07445347 | Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic... | Poitiers University Hospital | Observational | Enrolling by invitation | Hereditary Hemorrhagic Telangiectasia (HHT), Pulmonary Hypertension, Bevacizumab | 111 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445347) |
| February 24, 2026 | NCT07430943 | Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation | Mona Lichtblau | Not applicable | Recruiting | Pulmonary Rehabilitation, Physical Activities, Exercise Therapy | 12 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430943) |
| February 24, 2026 | NCT07429552 | Dynamic Mixed Learning Module in Pulmonary Hypertension Patients | Acibadem University | Not applicable | Completed | Pulmonary Hypertension, Nursing Care, Learning | 49 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07429552) |
| February 18, 2026 | NCT07416331 | Impact Of Using LevosemidanVersus DobutamineOn Right Ventricular Function In AdultPatients Undergoing Elective Valve Replacement Surgery | Helwan University | Observational | Completed | Right Ventriculaire Dysfunction, Pulmonary Hypertension | 52 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416331) |
| January 26, 2026 | NCT07366879 | Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension | Golden Jubilee National Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension | 40 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07366879) |
| January 22, 2026 | NCT07359599 | The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension | Ziekenhuis Oost-Limburg | Phase 4 | Recruiting | Pulmonary Hypertension, Iron Deficiency | 306 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359599) |
| January 15, 2026 | NCT07344207 | GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial) | Taipei Veterans General Hospital, Taiwan | Not applicable | Not yet recruiting | Pulmonary Hypertension (Diagnosis), Pre-operative Assessment, Postoperative Complications (Cardiopulmonary), Treatment... | 1,380 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07344207) |
| January 12, 2026 | NCT07333183 | A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD | Pulmovant, Inc. | Phase 2 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease (ILD), Lung Diseases, Vascular Diseases, Cardiovascular Diseases... | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333183) |
| January 7, 2026 | NCT07322133 | Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) | University of California, Davis | Phase 4 | Recruiting | Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory Failure | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322133) |
| January 6, 2026 | NCT07318597 | Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) | Regeneron Pharmaceuticals | Phase 2 | Recruiting | Pulmonary Arterial Hypertension (PAH) | 99 | Australia, Belgium, France, Germany, Latvia, Poland, South Korea, Spain, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318597) |
| December 30, 2025 | NCT07311135 | Accuracy of Smartwatches in Measuring Oxygen Levels in Patients With Pulmonary Hypertension: A Pilot Study | Golden Jubilee National Hospital | Observational | Recruiting | Pulmonary Hypertension | 20 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07311135) |
| December 30, 2025 | NCT07311044 | CVD/PH and Voice Characteristics | Mayo Clinic | Observational | Recruiting | Pulmonary Hypertension, Cardiovascular Diseases | 7,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07311044) |
| December 18, 2025 | NCT07292896 | A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by... | First Hospital of China Medical University | Observational | Not yet recruiting | Healthy Adults, Pulmonary Hypertension, Tricuspid Regurgitation, Heart Failure, Atrial Septal Defect | 2,640 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292896) |
| December 16, 2025 | NCT07285655 | A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Liquidia Technologies, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension Due to Lung Disease (Disorder) | 344 | Australia, Austria, Belgium, Canada, France, Germany, Italy, Latvia, Portugal... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285655) |
| December 4, 2025 | NCT07263958 | Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD) | University of Sao Paulo General Hospital | Not applicable | Not yet recruiting | Pulmnary Hypertension, COPD, Pulmonary Hypertension Secondary to Lung Disease and/or Hypoxia | 15 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263958) |
| November 28, 2025 | NCT07253363 | Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension | Assistance Publique - Hôpitaux de Paris | Not applicable | Active not recruiting | Pulmonary Hypertension | 550 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07253363) |
| November 25, 2025 | NCT07247240 | Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia | Asan Medical Center | Phase 4 | Not yet recruiting | Congenital Diaphragmatic Hernia, Pulmonary Hypertension | 40 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247240) |
| November 19, 2025 | NCT07236970 | Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With... | Alejandro Cruz Utrilla | Observational | Recruiting | Pulmonary Hypertension, Systemic Sclerosis (SSc), Systemic Sclerosis-Associated PAH | 350 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07236970) |
| November 18, 2025 | NCT07234032 | An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | Czechia, France, Georgia, Germany, Japan, South Korea, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07234032) |
| November 5, 2025 | NCT07224906 | Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization | HemoCept Inc. | Observational | Recruiting | Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224906) |
| November 3, 2025 | NCT07223528 | TEPH: Telaglenastat Efficacy in Pulmonary Hypertension | Chan, Stephen, MD, PhD | Phase 1/2 | Not yet recruiting | Pulmonary Hypertension | 28 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223528) |
| October 28, 2025 | NCT07221513 | Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension | Salubris Biotherapeutics Inc | Phase 2 | Withdrawn | HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction, Group 2... | 0 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07221513) |
| October 16, 2025 | NCT07217522 | Rutgers University Study of the Genetics of Pulmonary Hypertension | Rutgers, The State University of New Jersey | Observational | Recruiting | Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)... | 10,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217522) |
| October 9, 2025 | NCT07214376 | A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in... | Pulnovo Medical, Inc. | Not applicable | Recruiting | Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases, Cardiovascular... | 750 | China, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214376) |
| October 7, 2025 | NCT07209956 | Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTis | University Hospital, Bordeaux | Not applicable | Completed | Bronchiolitis, Viral | 46 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209956) |
| October 6, 2025 | NCT07207525 | Information Sources in Pulmonary Hypertension | University of Sao Paulo General Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 100 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07207525) |
| October 3, 2025 | NCT07206173 | Londrina Activities of Daily Living Protocol in Pulmonary Hypertension | Saglik Bilimleri Universitesi | Observational | Completed | Pulmonary Hypertension | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206173) |
| October 2, 2025 | NCT07202793 | Effectiveness and Tolerance of Respiratory Rehabilitation in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | Poitiers University Hospital | Observational | Completed | COPD, Pulmonary Hypertension | 59 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07202793) |
| September 25, 2025 | NCT07193173 | Is the Two-minute Step Test an Alternative to the Six-minute Walk Test in Pulmonary Hypertension? | Saglik Bilimleri Universitesi | Observational | Active not recruiting | Pulmonary Hypertension | 35 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07193173) |
| September 22, 2025 | NCT07187206 | Safety and Efficacy of FETO in CDH Phase III | Children's Hospital Medical Center, Cincinnati | Phase 3 | Recruiting | Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary Hypertension | 75 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187206) |
| September 22, 2025 | NCT07184671 | Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary... | Assistance Publique Hopitaux De Marseille | Observational | Not yet recruiting | Pulmonary Hypertension, Chronic Pulmonary Disease | 105 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184671) |
| September 19, 2025 | NCT07184060 | Echocardiographic Assessment of Pulmonary Hypertension in Obstructive Sleep Apnea | Assiut University | Observational | Not yet recruiting | Obstructive Sleep Apnea (OSA), Pulmonary Hypertension | 55 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184060) |
| September 18, 2025 | NCT07181382 | Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | GB002, Inc. | Phase 3 | Suspended | Pulmonary Hypertension Associated With Interstitial Lung Disease | 480 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07181382) |
| September 17, 2025 | NCT07179380 | Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | Argentina, Australia, Austria, Belgium, Brazil, Colombia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179380) |
| September 16, 2025 | NCT07176260 | Exploring Blood Cell Function and Oxidative Stress to Improve Diagnosis and Treatment in Pre-Capillary Pulmonary Hypertension | University Hospital, Strasbourg, France | Observational | Recruiting | Pre-capillary Pulmonary Hypertension | 120 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07176260) |
| September 16, 2025 | NCT07175038 | A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung... | AllRock Bio, Inc. | Phase 2 | Recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease | 40 | Australia, Canada, France, Germany, Italy, Latvia, Poland, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07175038) |
| September 15, 2025 | NCT07172334 | What is the Role of the Exposome in Pulmonary Hypertension | Poitiers University Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | 150 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07172334) |
| September 10, 2025 | NCT07164157 | The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary Hypertension | Wei Huang | Observational | Completed | Pulmonary Arterial Hypertension, Air Pollution, Maternal Outcome | 1,200 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07164157) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Assiut University | 7 | September 22, 2026 |
| Silvia Ulrich Somaini | 7 | September 4, 2026 |
| University of Sao Paulo General Hospital | 5 | March 5, 2026 |
| Poitiers University Hospital | 4 | August 12, 2026 |
| Merck Sharp & Dohme LLC | 3 | October 28, 2026 |
| Mayo Clinic | 3 | December 30, 2025 |
| Assistance Publique - Hôpitaux de Paris | 3 | November 28, 2025 |
| Insmed Incorporated | 3 | November 18, 2025 |
| United Therapeutics | 2 | November 6, 2026 |
| Universidad Complutense de Madrid | 2 | November 4, 2026 |
| Ain Shams University | 2 | October 30, 2026 |
| China National Center for Cardiovascular Diseases | 2 | September 28, 2026 |
| Pulmovant, Inc. | 2 | September 11, 2026 |
| Children's Hospital Medical Center, Cincinnati | 2 | March 17, 2026 |
| Golden Jubilee National Hospital | 2 | January 26, 2026 |
| Saglik Bilimleri Universitesi | 2 | October 3, 2025 |
| RenJi Hospital | 2 | September 2, 2025 |
| Imperial College London | 2 | August 29, 2025 |
| Eko Devices, Inc. | 2 | August 22, 2025 |
| Southeast University, China | 1 | November 5, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 69 | October 1, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 38 | November 4, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 14 | November 6, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 8 | September 24, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 4 | October 28, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 4 | April 21, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 3 | September 24, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | November 6, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 2 | March 28, 2025 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 42 | November 6, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 20 | November 5, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 17 | August 12, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 13 | August 17, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 11 | November 4, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 11 | September 4, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 9 | April 6, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 8 | June 25, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 6 | September 16, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 6 | August 26, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 6 | May 4, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 6 | March 16, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 6 | January 22, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 5 | July 10, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 5 | January 6, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 4 | April 29, 2026 |
| [Czechia](https://specstream.ai/data/clinical-trials/country/czechia) | 4 | November 18, 2025 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 3 | June 30, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 3 | January 15, 2026 |
| [Latvia](https://specstream.ai/data/clinical-trials/country/latvia) | 3 | January 6, 2026 |
| [Austria](https://specstream.ai/data/clinical-trials/country/austria) | 3 | December 16, 2025 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 3 | November 18, 2025 |
| [Israel](https://specstream.ai/data/clinical-trials/country/israel) | 3 | September 18, 2025 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 2 | June 23, 2026 |
| [Colombia](https://specstream.ai/data/clinical-trials/country/colombia) | 2 | April 21, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).